chr18-60372165-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_005912.3(MC4R):āc.185A>Gā(p.Asn62Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,614,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ).
Frequency
Consequence
NM_005912.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC4R | NM_005912.3 | c.185A>G | p.Asn62Ser | missense_variant | 1/1 | ENST00000299766.5 | NP_005903.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC4R | ENST00000299766.5 | c.185A>G | p.Asn62Ser | missense_variant | 1/1 | NM_005912.3 | ENSP00000299766 | P1 | ||
ENST00000658928.1 | n.156+42820T>C | intron_variant, non_coding_transcript_variant | ||||||||
ENST00000650201.1 | n.113+42820T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251328Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135828
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74500
ClinVar
Submissions by phenotype
Obesity due to melanocortin 4 receptor deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 28, 2018 | The p.Asn62Ser variant in MC4R has been reported in the homozygous state in 1 individual with severe obesity, and segregated with disease in 4 homozygous and 4 heterozygous affected relatives (Farooqi 2003, Farooqi 2003). Of note, the homozygous individuals in this family were more severely affected than the heterozygous individuals. This variant has been identified in 1/30782 South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/). In vitro functional studies provide some evidence that the p.Asn62Ser variant may impact protein function (Tao 2003, Yeo 2003); however, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analysis suggest that the p.Asn62Ser variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, the p.Asn62Ser variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PP1_Moderate, PP3, PS3_Supporting. - |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 20, 2003 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at